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AN excess of spontaneous hepatoma in male over breeding CBA female mice,
first recorded by Gorer (1940), was confirmed (Pybus and Miller, 1942; Miller
and Pybus, 1945) and a similar disparity in sex incidence was found in the related
C3H strain (Burns and Schenken, 1940, 1943; Andervont, 1950). These observa-
tions led to experiments to test the suggestion that androgen might be a causative
factor in the induction of spontaneous hepatoma. Tests for a possible hepatoma-
inducing effect ofandrogens in females and a reducing effect ofoestrogens in males
were made by Andervont (1950), but the results were judged to be inconclusive.
Subsequently Agnew and Gardner (1952) concluded from their experiments that
prevention or modification of incidence of hepatoma depended on the amount
of oestrogen given rather than its excess over androgen and that the effective
quantity might vary in different strains.
Data concerning virgin females have been reported less frequently and in
comparatively small groups of mice (Burns and Schenken, 1943; Andervont,
1950: Table I), although Heston and Deringer (1953) found 17 mice with hepa-
toma in 100 C3Hf virgins that lived to an average age of 19*9 months. In RIlIf
and C3Hf virgin females it was found that hepatomas occurred as frequently as
in males and significantly more often than in breeding females ofthe same strains
(Pullinger and Iversen, 1960). Observations on the nippie areas of the C3Hf
females and experiments on ovariectomised females and castrated males, alone
or followed by the application of oestrogen, supported the conclusion of Agnew
and Gardner (1952) that mere excess of oestrogen over androgen did not afford
protection against hepatoma.
It seemed possible that the relative protection in breeding females might be
due to the larger amounts of oestrogens secreted in pregnancy. Very great
increases of oestrone, oestradiol-17,/ and oestriol have been found in the pregnant
human female (Brown, 1956). No method for measuring oestrogen secretion in
mice had been devised when these observations were made. But data previously
obtained in experiments on mammary carcinoma in which differing amounts of
some human oestrogens, oestrone, oestradiol-17,8 and oestriol were applied after
ovariectomy or castration, were examined for indirect evidence of an association
between reduction of hepatoma and hyper-oestrinisation. Though reductions in
incidence were obtained, these were not statistically significant when small
amounts of oestrogens were given. The reduction obtained with larger amounts
was accompanied by complications which reduced survival rate and age. It
seems possible that intermediate amounts ofoestrogens would be worth testing for
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METHODS AND MATERIALS
C3Hf mice were derived from a litter in the F/23 generation, given to this
Hospital in 1954 by Dr. W. E. Heston, who obtained this substrain by Caesarian
section and cross-suckling from Andervont's C3HfJine (Andervont and McEleney,
1941). Breeding has been carried out by brother and sistermatings. The average
number oflitters was 5, ranging from 1 to 12 (Pullinger and Iversen, 1960). Food
in the form of cubes of composition 41 (of M.R.C.'s Laboratory Animals Centre)
and drinking water were supplied ad libitum. Bilateral ovariectomies were done
under bromethol anaesthesia, at 56 to 111 days of age. The ovaries and greater
part of the uterine horns were removed, the cut ends being crushed but not tied,
in order to avoid foreign body reactions. Oestrogens in acetone solution from
graduated 0-2 ml. pipettes were applied weekly to the clipped skin of the dorsal
surface for 60 weeks. The solutions were stored in glass-stoppered bottles in an
atmosphere ofacetone in alargerglass-stoppered container toprevent evaporation.
This regular method ofapplication was chosen in expectation ofregular absorption
of similar amounts in preference to implantation of pellets which often become
encysted in avascular fibrous tissue. Pellets may also interfere with subsequent
observations on nipple areas. Actual absorption rate could not be measured.
It had previoulsy-been found (Pullinger, 1947, 1957) that absorption occurred
-through the skin ofall strains tested. Mice were killed only whenill orifa tumour
had developed. At post mortem it was ascertained that no ovaries or fragments
remained. Castration and treatment of males was done similarly and no rem-
nants of prostate glands were found at post mortem examination. Pituitary
glands of all mice were examined macroscopically but none was enlarged as a
consequence of application of oestrogens. Stained whole mounts of all 10 nipple
regions of females and male mammary rudiments were examined as previously
described (Pullinger, 1947). All 10 nipple regions of samples of not less than 12
mice were examined. Greater reliance for evidence of the influence ofoestrogens
was placed on mammary gland developments than on vaginal cornification, as
described by Pullinger (1959, 1960a, b, 1961). Nevertheless frequent tests for
cornification were made by the method of Parkes (1926) when such information
was needed.
The mice were treated as recorded below
Group I, normal breeding and virgin females and normal males.
Group II, ovariectomised virgin females and castrated males.
Group III ovariectomised virgin females and castrated males treated with
oestrogens in the following dosage:
5 ,ug. oestrone weekly for 60 weeks to both sexes;
10 ,ug. oestrone weekly for 60 weeks to females only, or a mixture of 10 jug.
oestrone, oestradiol-17,8 and oestriol in equal parts or 10 Fug. oestriol or
200 ,ug. oestriol weekly for the same period to females only.
Group IV, consisted of normal males treated with 5 jag. oestrone weekly.
RESULTS
(a) Hepatoma incidence
Hepatoma is a disease oflater life and has not been found in C3Hfmice in this
department under 16 months of age. Only animals that lived to the lowest
hepatoma age or exceeded it are included in the results which are summarised
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in Table I. Breeding females had a significantly lower incidence of hepatomas
than virgin or ovariectomised females or breeding or castrated males (Groups I
and II). Oestrogens at all levels tended to reduce the number of hepatomas in
spayed females and males except for oestriol at the lowest dosage (10 jug.), Oest-
rone (10 ,tg.) and oestriol (200 ,tg.) did so significantly in ovariectomised females
(Group III).
TABLE I.-Hepatoma Incidence in Breeding Females and Intact C3HfFemales and
Males Aged 16 Months or More Compared With Those Gonadectonised or
Treated With Ovarian Hormones Weekly
Number Number Percentage
of with with
Group Hormonal conditions mice Hepatoma Hepatoma
I . Breeding females . 103 . 7 . 6-8
Virgin females . 110 . 27 24-5
Breeding males . 71 . 20 28 2
II . Ovariectomised females . 32 . 8 250
Castrated males . 25 . 8 32-0
III . Ovariectomised females
+ oestrone 5 pg. per week . 33 . 5 . 15-1
+ oestrone 10 Ag.,,,,. 38 . 2 5-2
+ oestriol
+ oestrone 10 ug.,,,. 41 5 . 12-2
+ oestradiol-17,
+ oestriol 10 ug.,,,. 34 . 10 29-4
± oestriol 200 ,ug. ,, ,, . 16 . 1 . 6 2
Castrated males
+ oestrone 5 pg. ,, ,, . 31 . 4 12-5
IV . Normal males
+ oestrone 5 ,g. ,,,,. 28 . 7 . 25.0
(b) Survival rates
The survival rates in the various groups are set out in Table II, in which mice
surviving less than 16 months are listed for information and those surviving 16
months and over are given at 5-month intervals. The average age of death of
mice in the various groups is included in Table II and shows that the difference
in hepatoma incidence between breeding females and virgin females and normal
males cannot be accounted for by difference in survival rate.
Ovariectomised females and castrated males had the same average age as
intact females and males, 28 and 25 months respectively.
In gonadectomised female mice treated with oestrogens the average age fell
with increased amounts of oestrogen from 29 months with 5 ,ug. oestrone to 22
months with 200 4ug. oestriol.
In castrated and intact males treated with 5 ,ug. oestrone the average age,
27 months, was slightly higher than in castrated and intact untreated males,
25 months.
(c) Evidence of the influence ofoestrogen
Of the 110 Group I virgins in Table I, the nipple regions of 93 were examined
by bulk staining. Lobular alveolar differentiation was similar in mice with and
without hepatoma (Table III). Mammary nodules were found in 35*5 per cent
of mice without hepatoma and in only 5 per cent of those with hepatoma. Pul-
linger (1959, 1960b, 1961) showed that administered oestrogen caused an increase
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TABLE II.-Survival Rate and Hepatoma Incidence in Breeding, Intact,
Gonadectomised, and Oestrogen-treated C3Hf Mice
Type of mouse
Breeding
Virgin
Breeding
Ovariectomised
Castrated
Ovariectomised
+ oestrone 5 Mg.
+ oestrone 10 ,ug.
oestrone )
4- oestriol -10 ,ug.
oestradiolJ
+ oestriol 10 ,ug.
+ oestriol 200 jug.
Castrated
+ oestrone 5 ug.
Intact
+ oestrone 5 pg.
Start
108
114
74
40
25
Mice dying at stated periods
(months)
0-15 16-20 21-25 26-30 31-35
0/5 0/11 2/25 3/45 2/22
0/4 */12 */14 */42 */42
0/3 4/18 6/17 9/32 1/4
0/8 */3 */4 */16 */9
0/0 1/7 1/4 4/10 2/4
39 0/6 0/2 3/3 2/15 0/13
50 0/12 1/14 1/8 0/11 0/5
42 0/1 1/10 1/12 2/16 1/3
34 0/0 1/3 4/11 4/17 1 /3
20 0/4 0/7 1/5 0/3 0/1
32 0/1 1/4 0/8 3/13 0/6
31 0/3 0/2 2/6 3/15 2/5
Incidence of Hepatomas in
mice aged 16 months
and over
Average
Percent- age
Number age (Months)
7/103 6-8 27
27/110 24-5 28
20/71 28-2 25
8/32 25/0 28
8/25 32 0 25
5/33 15-1 29
2/38 5-2 24
5/41 12/2 25
10/34 29-4
1/16 6/2
26
22
4/31 12- 5 27
7/28 25 0 27
* Results not available.
Numerator = Number of mice with hepatoma.
Denominator = Number of mice.
TABLE III.-Mammary Gland Development in C3Hf Virgin Female Mice
With and Without Spontaneous Hepatoma
With hepatoma
Without hepatoma .
Number
of mice
20
73
Number with
lobular-alveolar
differentiation
14 (70.0%)
53 (72 6%)
in mammary nodules and it is thus suggested that the non-hepatoma virgin mice
had a greater endogenous secretion of oestrogen than those bearing hepatomas.
As far as the oestrogen-treated ovariectomised mice were concerned (Group
III, Table I) vaginal cornification occurred at every dose level, including 10 ,tg.
oestriol, indicating that the mice were effectively under the influence of the hor-
mone. The mammary rudiments of oestrogen-treated castrated males (Group
III) were also examined. Outgrowth of ducts and alveolar nodules were more
evident in mice without than with hepatoma (Table III).
(d) Complicating factors
(i) Diet.-The incidence of hepatomas in mice was reduced when diets were
deficient in calories or proteins (Tannenbaum and Silverstone, 1949). The diet
given to all the mice during the present experiments remained constant and was
not deficient in protein or choline. Thus differences in incidence of hepatomas
in oestrogen-treated groups was not thought to be due to dietary differences,
unless illness reduced appetite.
Sex
F
F
M
F
M
F
M
M
Number
with
nodules
.1 (5.0%) .
26 (35-6%)
Number
with
carcinoma
0
2
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(ii) Body weight.-Rapid growth of mice was found by Heston, Deringer and
Vlahakis (1960) to favour a high incidence of hepatoma. Body weight remained
normal except in the experiment with 200 ,ug. oestriol (Fig. 1) in which it was
reduced.
(iii) Occurrence of bladder calculi.-Urinary calculi developed in 17 out of 44
ovariectomised females treated with 10 /tg. oestrone; 6 of these died between 12
and 16 months of age and all had calculi. Not all the animals were ill but this
complication appeared to be effective in reducing survival rate. Of 41 ovariec-
tomised females treated with a mixture of oestrone, oestradiol and oestriol 6
developed calculi and survival was nearer that of intact mice. No bladder calculi
developed in mice treated with either dose of oestriol.
28-
27-
26 7¾
25 /
24 /
.23
22- n X < /
21/
19
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34
Age in months
FIG. 1. L * Virgin females.
x x + 200 tLg. oestriol weekly foi 60 weeks after ovariectoiny.
(iv) Occurrence of tumours.-Mammary carcinomas were more frequent in
mice receiving the larger doses of oestrogen ; 33.3 per cent of those treated with
200 ,ug. oestriol developed mammary tumours and where a mixture of oestrone,
oestradiol and oestriol was given the occurrence ofmammary carcinoma shortened
life.
(v) Production of post-castrational oestrogens and androgens.-There was evi-
dence of some post-castrational oestrogen secretion in the 32 ovariectomised
females and 25 castrated males in Group II (Table I) although in these mice the
hepatoma incidence remained high. Sufficient oestrogen had been secreted in
castrate males to induce outgrowth of the breast rudiments in all of 12 mice
examined. In the ovariectomised females adrenal cortical hyperplasia occurred
in 5 mice only, and a female type of glomerular capsule lining in 6 only. In
only 1 mouse was there a change in sex character of the salivary glands. Nodules
in the breast occurred in only 3*6 per cent of ovariectomised female mice, in
comparison with 29 per cent in intact females. No evidence of post-castrational
androgen was found in either sex.
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DISCUSSION
A lower incidence of hepatomas in breeding females compared with virgin
females and males was confirmed in the C3Hf mice used in these experiments.
This is in accordance with the findings of other authors working with this strain.
Ovariectomy in females and castration in males had no effect on the incidence of
hepatomas compared with that in intact animals. Although there was evidence
of some post-castrational secretion of oestrogen in males, it did not affect the
incidence of hepatoma. Administration of oestrogen to castrated males and
females tended to lower the hepatoma incidence even when the dose was small,
but this decrease did not beome statistically significant unless a fairly large dose
of oestrone or a large dose of oestriol was given.
It is necessary in estimating the effects of treatment that survival ages must
be comparable with normal because hepatoma arises late in life. In the C3Hf
strain in these laboratories it was first seen at 16 months old-, and only mice of
16 months and older are included in the results. Large amounts of oestrogens
which significantly lowered hepatoma incidences, reduced survival rates also.
Thus although treatment with 10 ,tg. oestrone and 200 tg. oestriol reduced the
hepatoma incidence in ovariectomised virgin females to that of breeders it is
possible that side effects such as bladder calculi with reduced survival rate and loss
in weight may have been partly responsible for this. It is suggested that inter-
mediate doses might be tested for an effect on hepatoma incidence.
SUMMARY
1. The incidence of hepatoma in C3Hf breeding females was 6-8 per cent, that
ofintact virgin females 24*5 per cent, and that ofovariectomised virgin females 25
per cent.
2. Hepatoma incidence in C3Hfmales was 29*8 per cent and in those castrated
was 32 per cent.
3. Survival rates of ovariectomised mice given 5 ,ug. oestrone or 10 ,ug. of a
mixture of oestrone, oestradiol and oestriol were similar to normal and ovariecto-
mised virgin females. Five ,tg. oestrone given to castrated males did not reduce
survival. Hepatoma incidences were 15X1, 12-2 and 12X5 per cent respectively.
4. Reduction in hepatoma incidence became statistically significant when
larger amounts of oestrogens were given, but 10 ,ug. oestrone reduced survival
and 200 ,tg. oestriol reduced weight and survival rate.
We wish to thank Dr. P. R. Peacock for his interest and advice and Dr. S.
Iversen for help with statistics.
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